CAPSONI, Simona
 Distribuzione geografica
Continente #
NA - Nord America 9.575
AS - Asia 4.362
EU - Europa 2.124
SA - Sud America 684
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 116
OC - Oceania 20
Totale 17.130
Nazione #
US - Stati Uniti d'America 9.397
SG - Singapore 1.699
CN - Cina 883
IT - Italia 538
BR - Brasile 529
VN - Vietnam 448
HK - Hong Kong 373
TR - Turchia 301
DE - Germania 272
UA - Ucraina 261
GB - Regno Unito 214
PL - Polonia 185
SE - Svezia 161
BD - Bangladesh 150
JP - Giappone 137
FR - Francia 134
FI - Finlandia 119
RU - Federazione Russa 105
IN - India 98
CA - Canada 76
MX - Messico 72
ID - Indonesia 66
AR - Argentina 49
ZA - Sudafrica 46
IQ - Iraq 45
NL - Olanda 32
EC - Ecuador 25
CO - Colombia 23
ES - Italia 22
PH - Filippine 22
AU - Australia 18
VE - Venezuela 18
MY - Malesia 17
PK - Pakistan 16
UZ - Uzbekistan 15
TN - Tunisia 13
AT - Austria 12
KR - Corea 12
MA - Marocco 12
SA - Arabia Saudita 12
CL - Cile 11
KE - Kenya 11
PY - Paraguay 10
CZ - Repubblica Ceca 9
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
SD - Sudan 7
AZ - Azerbaigian 6
BO - Bolivia 6
CH - Svizzera 6
EG - Egitto 6
JM - Giamaica 6
KZ - Kazakistan 6
UY - Uruguay 6
BE - Belgio 5
DZ - Algeria 5
IE - Irlanda 5
IL - Israele 5
IR - Iran 5
NP - Nepal 5
TH - Thailandia 5
CR - Costa Rica 4
GR - Grecia 4
GT - Guatemala 4
OM - Oman 4
PE - Perù 4
PT - Portogallo 4
BG - Bulgaria 3
GY - Guiana 3
HN - Honduras 3
JO - Giordania 3
KH - Cambogia 3
PS - Palestinian Territory 3
RO - Romania 3
BB - Barbados 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
GD - Grenada 2
GE - Georgia 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
Totale 16.862
Città #
Ashburn 1.073
Singapore 978
Fairfield 899
Woodbridge 794
San Jose 654
Houston 603
Ann Arbor 436
Chandler 418
Jacksonville 405
Hong Kong 366
Santa Clara 366
Seattle 353
Beijing 305
Cambridge 303
Wilmington 291
Council Bluffs 272
Warsaw 182
Izmir 171
Ho Chi Minh City 151
Los Angeles 138
Tokyo 132
Milan 128
Hanoi 109
Nanjing 108
Boardman 100
Princeton 98
Dallas 97
Lauterbourg 96
New York 92
San Diego 73
The Dalles 60
Rome 56
Ferrara 50
Jakarta 50
Chicago 49
São Paulo 47
Dearborn 45
Addison 41
Nanchang 41
Munich 39
Columbus 38
Falls Church 38
London 35
Mexico City 34
Boydton 31
Orem 31
Phoenix 31
Brooklyn 29
Toronto 28
Shenyang 27
Hebei 26
Moscow 26
Shanghai 26
Denver 24
Des Moines 24
Tianjin 24
Atlanta 23
Buffalo 23
Chennai 23
Helsinki 23
Jiaxing 23
Rio de Janeiro 23
Mountain View 21
San Francisco 21
Haiphong 20
Johannesburg 20
Stockholm 20
Changsha 19
Bursa 17
Da Nang 17
Redwood City 17
Boston 16
Baghdad 15
Manchester 15
Mumbai 15
Nuremberg 15
Turin 15
Montreal 14
Norwalk 13
New Delhi 12
Belo Horizonte 11
Dong Ket 11
Guangzhou 11
Kunming 11
Poplar 11
Cincinnati 10
Hefei 10
Perth 10
Tashkent 10
Cape Town 9
Frankfurt am Main 9
Kuala Lumpur 9
Medellín 9
Quito 9
Amsterdam 8
Ankara 8
Brasília 8
Lahore 8
Lanzhou 8
Secaucus 8
Totale 11.769
Nome #
NGF steers microglia toward a neuroprotective phenotype 331
Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy 317
Environmental enrichment delays the onset of memory deficits and reduces neuropathological hallmarks in a mouse model of Alzheimer-like neurodegeneration 251
Alzheimer-like neurodegeneration in aged antinerve Growth factor transgenic mice 234
Amyloid plaque-independent deficit of early postnatal visual cortical plasticity in the 5xFAD transgenic model of Alzheimer's disease. 233
Non-human transgenic animals for the study of neurodegenerative syndromes 233
Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis 231
A small molecule targeting the multifactorial nature of Alzheimer's disease 228
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice 227
Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice 226
A dual mechanism linking NGF/ProNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model 223
The chemokine CXCL12 mediates the anti-amyloidogenic action of painless human nerve growth factor 223
Dark rearing blocks the developmental down-regulation of brain-derived neurotrophic factor messenger RNA expression in layers IV and V of the rat visual cortex 221
Autoradiographic localization of putative melatonin receptors in the brains of two old world primates: Cercopithecus aethiops and Papio ursinus 220
Understanding pain perception through genetic painlessness diseases: The role of NGF and proNGF 220
A carnivore species (Canis familiaris) expresses circadian melatonin rhythm in the peripheral blood and melatonin receptors in the brain 217
Taking pain out of NGF: a "painless" NGF mutant, linked to hereditary sensory autonomic neuropathy type V, with full neurotrophic activity 210
2-Bromomelatonin: synthesis and characterization of a potent melatonin agonist 204
Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice 203
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice 199
Gene expression biomarkers in the brain of a mouse model for Alzheimer's disease: Mining of microarray data by logic classification and feature selection 193
Failure of nicotine-dependent enhancement of synaptic efficacy at Schaffer-collateral CA1 synapses of AD11 anti-nerve growth factor transgenic mice 191
On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer’s disease 190
Electrophysiological and behavioral effect of ozone on mice olfactory bulb 189
ProNGF drives localized and cell selective parvalbumin interneuron and perineuronal net depletion in the dentate gyrus of transgenic mice 188
Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies 187
Functional Characterization of Human ProNGF and NGF Mutants: Identification of NGF P61SR100E as a "Painless" Lead Investigational Candidate for Therapeutic Applications 185
Neutralization of Nerve Growth Factor impairs proliferation and differentiation of adult neural progenitors in the subventricular zone 184
Pathogen-Free Husbandry Conditions Alleviate Behavioral Deficits and Neurodegeneration in AD10 Anti-NGF Mice. 177
Dissecting the involvement of tropomyosin-related kinase A and p75 neurotrophin receptor signaling in NGF deficit-induced neurodegeneration 176
Intranasal "painless" human nerve growth factors slows amyloid neurodegeneration and prevents memory deficits in app x PS1 mice 176
SorLA Deficiency Dissects Amyloid Pathology from Tau and Cholinergic Neurodegeneration in a Mouse Model of Alzheimer's Disease 176
A Microglial Function for the Nerve Growth Factor: Predictions of the Unpredictable 175
Cholinergic striatal neurons are increased in HSAN V homozygous mice despite reduced NGF bioavailability 174
Intranasal delivery of therapeutic proteins for neurological diseases 173
Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities 173
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE 172
Antagonization of NGF in adult mice by transgenic antibodies causes progressive learning and memory impairments 171
Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons 170
Postnatal development of GFAP in mouse visual cortex is not affected by light deprivation 169
Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models 168
The positional identity of mouse ES cell-generated neurons is affected by BMP signaling 167
Development of a non invasive NGF-based therapy for Alzheimer's disease 165
Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice 163
Characterization of endothelinA receptors in cerebral and peripheral arteries of the rat 162
Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation 162
Nerve growth factor regulates axial rotation during early stages of chick embryo development 161
Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice 160
Rat visual cortical neurones express TrkA NGF receptor 158
In vitro receptor binding properties of a "painless" NGF mutein, linked to hereditary sensory autonomic neuropathy type V 158
Towards non invasive nerve growth factor therapies for Alzheimer's disease 158
Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice 157
Localization and characterization of melatonin binding sites in the brain of the rabbit (Oryctolagus cuniculus) by autoradiography and in vitro ligand-receptor binding 157
Reduction of regional cerebral blood flow by melatonin in young rats 157
Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody 156
In the adult hippocampus, chronic nerve growth factor deprivation shifts GABAergic signaling from the hyperpolarizing to the depolarizing direction 156
Nerve growth factor scales endocannabinoid signaling by regulating monoacylglycerol lipase turnover in developing cholinergic neurons 155
Ganstigmine and donepezil improve neurodegeneration in AD11 antinerve growth factor transgenic mice 153
Differential regulation of brain-derived neurotrophic factor messenger RNA cellular expression in the adult rat visual cortex 153
Effects of the cholinesterase inhibitor galantamine in a mouse model of Alzheimer's disease, the anti-nerve growth factor AD11 transgenic mice 152
Melatonin signal transduction and mechanism of action in the central nervous system: Using the rabbit cortex as a model 150
Painless Nerve Growth Factor: A TrkA biased agonist mediating a broad neuroprotection via its actions on microglia cells 150
Endogenous A beta causes cell death via early tau hyperphosphorylation 149
Mismatch between BDNF mRNA and protein expression in the developing visual cortex: the role of visual experience 147
Peripheral Neutralization of Nerve Growth Factor Induces Immunosympathectomy and Central Neurodegeneration in Transgenic Mice 147
Pathogen free conditions slow the onset of neurodegeneration in a mouse model of nerve growth factor deprivation 146
Muscular dystrophy in adult and aged anti-NGF transgenic mice resembles an inclusion body myopathy 145
From genes to pain: nerve growth factor and hereditary sensory and autonomic neuropathy type V 143
Graphene Promotes Axon Elongation through Local Stall of Nerve Growth Factor Signaling Endosomes 141
Distribution and characterization of the melatonin receptors in the hypothalamus and pituitary gland of three domestic ungulates 140
Characterization by Gene Expression Analysis of Two Groups of Dopaminergic Cells Isolated from the Mouse Olfactory Bulb 139
Non-human transgenic animals for the study of neurodegenerative syndromes 137
The NGFR100W Mutation Specifically Impairs Nociception without Affecting Cognitive Performance in a Mouse Model of Hereditary Sensory and Autonomic Neuropathy Type V 137
Long-term memantine treatment prevents behavioral deficits in a mouse model of sporadic Alzheimer's disease 136
The retina as a window to early dysfunctions of Alzheimer's disease following studies with a 5xFAD mouse model 136
A p75 neurotrophin receptor‐sparing nerve growth factor protects retinal ganglion cells from neurodegeneration by targeting microglia 133
Nerve Growth Factor regulates astrocyte physiology in vivo 131
Rescue of the neurodegenerative phenotype in AD11 anti-NGF mice 128
Alzheimer-like neurodegeneration in aged anti-nerve growth factor mice 127
Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis 127
INIBITORE DI TNF ALPHA ASTROCITARIO PER L’USO NEL TRATTAMENTO DI MALATTIE NEUROLOGICHE 125
Interaction between NH2-tau fragment and Aß in AD mitochondria contributes to the synaptic deterioration 122
Receptor for advanced glycation end product-dependent activation of p38 mitogen-activated protein kinase contributes to amyloid-beta-mediated cortical synaptic dysfunction 122
Distribution and pharmacological characterization of melatonin receptors in the brain of the Japanese quail (Coturnix japonica) 119
Memoquin: A new therapeutic poly-agent for Alzheimer's disease 116
Muteins of hNGF, therapeutic uses and pharmaceutical compositions 116
Nerve Growth Factor Neutralization Promotes Oligodendrogenesis by Increasing miR-219a-5p Levels 115
Involvement of Bradykinin Receptor 2 in Nerve Growth Factor Neuroprotective Activity 113
Expression of the melatonin receptor in Xenopus laevis: A comparative study between protein and mRNA distribution 111
Vasoactive intestinal peptide-like immunoreactive fibers in the pineal gland of the sheep 110
Unraveling the Role of Dopaminergic and Calretinin Interneurons in the Olfactory Bulb 108
Role and Characterization of Dopaminergic Interneurons in Mouse Olfactory Bulbs 105
Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve growth factor mice 104
Inhibitor of astrocyte TNF alpha for use in the treatment of neurological diseases 103
null 100
Enteric Alpha-Synuclein Inclusions, Colonic Inflammation, Increased Mucosal Permeability and Alterations of Bowel Neuromuscular Functions Precede Central Neurodegeneration in a Transgenic Mouse Model of Parkinson's Disease 98
Taking pain out of NGF: a "painless" NGF mutant with full neurotrophic activity 95
Reversal of neurological deficits by painless nerve growth factor in a mouse model of Rett syndrome 94
null 89
Getting Into the Brain: The Intranasal Approach to Enhance the Delivery of Nerve Growth Factor and Its Painless Derivative in Alzheimer’s Disease and Down Syndrome 89
Totale 16.361
Categoria #
all - tutte 78.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.709


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022787 0 0 84 33 39 40 61 62 31 81 84 272
2022/20231.036 141 60 12 134 158 124 121 86 123 9 50 18
2023/2024471 53 66 19 20 24 41 10 31 3 32 16 156
2024/20252.158 28 52 171 67 271 167 73 168 314 265 368 214
2025/20266.082 480 296 590 700 797 310 902 307 555 657 297 191
2026/2027685 205 287 193 0 0 0 0 0 0 0 0 0
Totale 17.130